INE963 (Novartis Institute for Tropical Diseases) is an oral, single dose, fast-acting blood-stage antimalarial candidate . The molecule was identified using a phenotypic high-throughput screening approach which has been successfully used to identify new antimalarial chemotypes . Phenotypic screens can be preferable to target-based [...]
4 minute read
Apr. 19, 2022
INE963: An Oral, Single Dose, Fast-Acting Antimalarial
INE963
oral blood stage antimalarial in Ph. I (healthy volunteers) from 1.5M cmpd phenotypic screen + opt. J. Med. Chem., March 1, 2022 Novartis (NIBR), Emeryville, CA
Reviewer:
Loading...
